Coordinador Académico de Cirugía TecSalud, Academia Mexicana de Cirugía
Monterrey, Nuevo León
Joined March 2020
- Tweets901
- Following315
- Followers580
- Likes3.1K
Adolfo Leyva retweeted
🔬 La obesidad mata a 2.8 millones de personas al año en el mundo y no tiene una sola causa. Por eso, el @IOR_Obesity del @TecdeMonterrey trabaja desde el 2022, generando investigación científica para mejorar la salud y el bienestar de las personas, con especial atención a la población mexicana.
🧬 Este centro reúne a expertos que abordan el problema desde múltiples frentes: Medicina Experimental y Terapias Avanzadas, Alimentos Saludables, Biología Integrativa, y Política y Emprendimiento Públicos. Juntos, desarrollan soluciones integrales para promover la salud metabólica y combatir la obesidad.
Adolfo Leyva retweeted
I’ve talked before about ’palming’ the needle holder versus putting your fingers in the holes…
But the next time an attending gives you a hard time for putting your fingers in the holes, you can point out to them that it’s *literally on the cover of the Sabiston textbook*. 🧐
Adolfo Leyva retweeted
The real cost? Doing nothing.
Untreated obesity brings serious health risks and lifelong burdens.
Metabolic Bariatric Surgery is an investment, not an expense.
#IFSO #bariatricsurgery #obesity
Adolfo Leyva retweeted
PANCREATITIS AGUDA: Guía IAP 2025 vs 2013
🔄 Tras 12 años, la IAP actualiza su guía con cambios clave.
📌 El diagnóstico se mantiene: 2 de 3
1️⃣ Dolor epigástrico
2️⃣ Lipasa/amílasa >3×
3️⃣ TC o USG con signos inflamatorios
🔍 Novedad: si sigue idiopática tras alta → repetir USG → EUS → RMN → genética si hay recurrencia.
Hay como 5 cirujanos aquí en Mty que dicen que hicieron la primer manga gástrica 🧐, estaban todos juntos ese día en algún multiverso??
Que lastima que nadie la publicó, y se las agandalló Michel G.
Adolfo Leyva retweeted
Medicare Part D Update: What’s the Deal with Obesity Meds?
📄 CMS just dropped its 2026 Medicare Final Rule—and guess what?
❌ Anti-Obesity Medications (AOMs) are still not covered under Part D.
Despite rising demand and strong evidence for meds like semaglutide, CMS said:
“CMS is also announcing that it is not finalizing three provisions from the proposed rule... including Part D Coverage of Anti-Obesity Medications (AOMs) and application to the Medicaid program.”
Translation:
🧓🏽 Seniors still can’t get coverage for evidence-based obesity meds through Medicare.
💊 GLP-1s for weight management remain excluded.
⏳ Future rulemaking? Possible. But for now, it’s another no.
#ObesityCare #MedicarePartD #HealthPolicy #GLP1 #Semaglutide #CMS #ObesityMedicine #HealthEquity #AccessToCare
cms.gov/newsroom/fact-sheets…
Adolfo Leyva retweeted
#ELDATO | De acuerdo con información de la OECD, México es el segundo país con mayor índice de obesidad en adultos
Adolfo Leyva retweeted
We are celebrating one year of @SURGhub!
What is SURGhub, and what are we trying to do? It's the global platform for training materials in surgical care.
If you're curious to learn more:
🎥 Watch the following video
📖 Read more about SURGhub here: globalsurgeryfoundation.org/…
